MX9204913A - Quinolilmetoxi-fenilcetamidas substituidas heterociclicamente, procedimiento para su fabricacion y medicamentos que las contienen. - Google Patents
Quinolilmetoxi-fenilcetamidas substituidas heterociclicamente, procedimiento para su fabricacion y medicamentos que las contienen.Info
- Publication number
- MX9204913A MX9204913A MX9204913A MX9204913A MX9204913A MX 9204913 A MX9204913 A MX 9204913A MX 9204913 A MX9204913 A MX 9204913A MX 9204913 A MX9204913 A MX 9204913A MX 9204913 A MX9204913 A MX 9204913A
- Authority
- MX
- Mexico
- Prior art keywords
- substituted
- quinolylmetoxy
- phenylcetamides
- heterociclicamente
- procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4129742A DE4129742A1 (de) | 1991-09-06 | 1991-09-06 | Heterocyclisch substituierte chinolylmethoxy-phenylacetamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9204913A true MX9204913A (es) | 1993-03-01 |
Family
ID=6440067
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9204913A MX9204913A (es) | 1991-09-06 | 1992-08-26 | Quinolilmetoxi-fenilcetamidas substituidas heterociclicamente, procedimiento para su fabricacion y medicamentos que las contienen. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5266578A (enExample) |
| EP (1) | EP0530639B1 (enExample) |
| JP (1) | JPH05194403A (enExample) |
| KR (1) | KR930006004A (enExample) |
| CN (1) | CN1070190A (enExample) |
| AT (1) | ATE110070T1 (enExample) |
| AU (1) | AU649351B2 (enExample) |
| CA (1) | CA2077465A1 (enExample) |
| CZ (1) | CZ276092A3 (enExample) |
| DE (2) | DE4129742A1 (enExample) |
| DK (1) | DK0530639T3 (enExample) |
| ES (1) | ES2057953T3 (enExample) |
| FI (1) | FI923968L (enExample) |
| HU (1) | HUT65660A (enExample) |
| IL (1) | IL103040A0 (enExample) |
| MX (1) | MX9204913A (enExample) |
| NO (1) | NO923181L (enExample) |
| NZ (1) | NZ244225A (enExample) |
| TW (1) | TW221431B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4219765A1 (de) * | 1992-06-17 | 1993-12-23 | Bayer Ag | Substituierte (Benzothiazolyl- und Chinoxalyl-methoxy)phenylessigsäurederivate |
| ES2062943B1 (es) * | 1993-03-23 | 1995-11-16 | Uriach & Cia Sa J | Nuevos derivados de la (2-metil-3-piridil) cianometilpiperazinas. |
| ATE188377T1 (de) * | 1993-06-29 | 2000-01-15 | Takeda Chemical Industries Ltd | Chinoline oder chinazolin-derivate und deren verwendung zur herstellung eines medikaments für die behandlung von osteoporose |
| ES2103180B1 (es) * | 1994-08-01 | 1998-04-01 | Menarini Lab | Fenilacetamidas con accion antagonista de los leucotrienos. |
| DE4443892A1 (de) * | 1994-12-09 | 1996-06-13 | Bayer Ag | 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate |
| EP0725063A1 (de) * | 1995-02-01 | 1996-08-07 | Ciba-Geigy Ag | Chinolin-Derivate |
| US6121300A (en) * | 1998-11-10 | 2000-09-19 | Wagle; Dilip R. | Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium salts |
| US6399641B1 (en) * | 2000-07-13 | 2002-06-04 | Hoffmann-La Roche Inc. | 2H-tetrazole-amide compounds with therapeutic activity as metabotropic glutamate receptor agonists |
| EP1664006A2 (en) * | 2003-09-06 | 2006-06-07 | Vertex Pharmaceuticals Incorporated | Modulators of atp-binding cassette transporters |
| KR102393675B1 (ko) * | 2021-08-20 | 2022-05-11 | (주)삼우공간건축사사무소 | 공동주택용 세대현관의 안전바닥패널 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63503139A (ja) * | 1986-03-13 | 1988-11-17 | ローラー インターナショナル（オーバーシーズ）インコーポレーテッド | 高血圧疾患治療剤としてのキノリニルエ−テル又はチオエ−テルテトラゾ−ル類 |
| DE3900261A1 (de) * | 1988-05-31 | 1989-12-07 | Bayer Ag | Substituierte 4-(chinolin-2-yl-methoxy) phenyl-essigsaeure-derivate |
| US5102881A (en) * | 1988-06-27 | 1992-04-07 | Merck Frosst Canada, Inc. | Quinoline ether alkanoic acids |
| DE3916663A1 (de) * | 1989-05-23 | 1990-11-29 | Bayer Ag | Substituierte (chinolin-2-yl-methoxy)phenyl-acyl-sulfonamide und -cyanamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
| US5041453A (en) * | 1990-05-30 | 1991-08-20 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Quinolinyl-benzoheterobicyclic derivatives as antagonists of leukotriene D4 |
-
1991
- 1991-09-06 DE DE4129742A patent/DE4129742A1/de not_active Withdrawn
-
1992
- 1992-08-07 TW TW081106243A patent/TW221431B/zh active
- 1992-08-14 NO NO92923181A patent/NO923181L/no unknown
- 1992-08-25 DK DK92114428.3T patent/DK0530639T3/da active
- 1992-08-25 ES ES92114428T patent/ES2057953T3/es not_active Expired - Lifetime
- 1992-08-25 DE DE59200387T patent/DE59200387D1/de not_active Expired - Fee Related
- 1992-08-25 AT AT92114428T patent/ATE110070T1/de not_active IP Right Cessation
- 1992-08-25 EP EP92114428A patent/EP0530639B1/de not_active Expired - Lifetime
- 1992-08-26 MX MX9204913A patent/MX9204913A/es unknown
- 1992-08-26 US US07/936,180 patent/US5266578A/en not_active Expired - Fee Related
- 1992-08-31 JP JP4253582A patent/JPH05194403A/ja active Pending
- 1992-09-01 AU AU22054/92A patent/AU649351B2/en not_active Ceased
- 1992-09-03 CA CA002077465A patent/CA2077465A1/en not_active Abandoned
- 1992-09-03 IL IL103040A patent/IL103040A0/xx unknown
- 1992-09-04 CZ CS922760A patent/CZ276092A3/cs unknown
- 1992-09-04 HU HU9202850A patent/HUT65660A/hu unknown
- 1992-09-04 FI FI923968A patent/FI923968L/fi unknown
- 1992-09-04 NZ NZ244225A patent/NZ244225A/en unknown
- 1992-09-05 CN CN92110346A patent/CN1070190A/zh active Pending
- 1992-09-05 KR KR1019920016241A patent/KR930006004A/ko not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP0530639A1 (de) | 1993-03-10 |
| CN1070190A (zh) | 1993-03-24 |
| HU9202850D0 (en) | 1992-11-30 |
| TW221431B (enExample) | 1994-03-01 |
| NO923181L (no) | 1993-03-08 |
| US5266578A (en) | 1993-11-30 |
| FI923968A0 (fi) | 1992-09-04 |
| KR930006004A (ko) | 1993-04-20 |
| FI923968A7 (fi) | 1993-03-07 |
| EP0530639B1 (de) | 1994-08-17 |
| DE4129742A1 (de) | 1993-03-11 |
| JPH05194403A (ja) | 1993-08-03 |
| DE59200387D1 (de) | 1994-09-22 |
| NO923181D0 (no) | 1992-08-14 |
| CA2077465A1 (en) | 1993-03-07 |
| AU649351B2 (en) | 1994-05-19 |
| NZ244225A (en) | 1994-08-26 |
| HUT65660A (en) | 1994-07-28 |
| ATE110070T1 (de) | 1994-09-15 |
| IL103040A0 (en) | 1993-02-21 |
| AU2205492A (en) | 1993-03-11 |
| DK0530639T3 (da) | 1994-12-05 |
| CZ276092A3 (en) | 1993-06-16 |
| FI923968L (fi) | 1993-03-07 |
| ES2057953T3 (es) | 1994-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT91158A (pt) | Processo para a preparacao de novos estirenos e carboxamidas heterociclicos biciclicos e composicoes farmaceuticas que os contem | |
| ES2097297T3 (es) | Isoquinolein-5-il-sulfonamidas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen. | |
| ES2074846T3 (es) | Nuevas naftil-etil-ureas y naftil-etil-tioureas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen. | |
| NO940277L (no) | Triglycerider og blandinger av slike | |
| MX9202982A (es) | Derivados de los acidos quinolon - y naftiridon - carboxilicos, procedimiento para su obtencion y medicamentos que los contienen. | |
| MX9204268A (es) | Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma. | |
| ATE88183T1 (de) | Substituierte 4-(chinolin-2-yl-methoxy)phenylessigs|ure-derivate. | |
| IT8349520A0 (it) | Derivati acidi idrossicarbossilici oligomeri, loro preparazione e loro impiego | |
| CO4290432A1 (es) | Nuevos derivados de pirazinacarboxamida, su preparacion y su utilizacion en medicamentos. | |
| AR024944A1 (es) | Amidas de acidos carboxilicos, medicamentos que contienen estos compuestos, su utilizacion y su preparacion | |
| ES2077199T3 (es) | Nuevas piperacinas 1,4-disustituidas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen. | |
| MX9201356A (es) | Derivados de piperidina, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
| MX9204637A (es) | Nuevos derivados de pirazina y procedimiento para su preparacion. | |
| MX9204913A (es) | Quinolilmetoxi-fenilcetamidas substituidas heterociclicamente, procedimiento para su fabricacion y medicamentos que las contienen. | |
| DE59308292D1 (de) | Substituierte triole | |
| IT8319306A0 (it) | Composizione di antralina oppure di uno dei suoi derivati in un estere aromatico e suo impiego nel trattamento di malattie della pelle e delle unghie. | |
| MX9204031A (es) | Sal de l-ascorbato de 16-descarboxi-16-hidroximetil-amfotericina b, proceso para su preparacion y composicion farmaceutica que contiene dicha sal. | |
| MX9205132A (es) | Derivados de acidos carboxilicos heterociclicos, procedimiento para su obtencion y medicamentos que los contienen. | |
| SE7612860L (sv) | Deoderant | |
| ES2059919T3 (es) | Amidas de acidos carboxilicos aromaticos, su obtencion y su utilizacion medicamentosa. | |
| DK0391185T3 (da) | 1,8-Naphthyridiner | |
| MX9204035A (es) | Composiciones liquidas que contienen esteres carboxilicos organicos. | |
| MX9201482A (es) | Acidos carboxilicos opticamente activos, proceso para su preparacion y composiciones farmaceuticas que los contienen. | |
| ES2060440T3 (es) | Derivados de acidos 1,4-dihidropiridin-dicarboxilicos aril-quinolil substituidos, procedimiento para su fabricacion y su uso en medicamentos. | |
| NO922642L (no) | Oktadecyl-(2-(n-metylpiperidino)-etyl)-fosfat og fremgangsmaate til dets fremstilling |